Holder Polar Securities Has Upped Bio Rad Labs (BIO) Stake; Roper Technologies (ROP) Shareholder Mcdonald Capital Investors Has Lowered Position as Valuation Rose

April 18, 2018 - By Adrian Mccoy

Roper Technologies, Inc. (NYSE:ROP) Logo

Mcdonald Capital Investors Inc decreased its stake in Roper Technologies Inc (ROP) by 3.1% based on its latest 2017Q4 regulatory filing with the SEC. Mcdonald Capital Investors Inc sold 1,865 shares as the company’s stock rose 6.89% while stock markets declined. The hedge fund held 58,230 shares of the capital goods company at the end of 2017Q4, valued at $15.08 million, down from 60,095 at the end of the previous reported quarter. Mcdonald Capital Investors Inc who had been investing in Roper Technologies Inc for a number of months, seems to be less bullish one the $28.46B market cap company. The stock increased 0.87% or $2.39 during the last trading session, reaching $276.73. About 452,179 shares traded. Roper Technologies, Inc. (NYSE:ROP) has risen 35.33% since April 18, 2017 and is uptrending. It has outperformed by 23.78% the S&P500.

Polar Securities Inc increased its stake in Bio Rad Labs Inc (BIO) by 69.55% based on its latest 2017Q4 regulatory filing with the SEC. Polar Securities Inc bought 67,595 shares as the company’s stock rose 2.21% while stock markets declined. The institutional investor held 164,790 shares of the capital goods company at the end of 2017Q4, valued at $39.33 million, up from 97,195 at the end of the previous reported quarter. Polar Securities Inc who had been investing in Bio Rad Labs Inc for a number of months, seems to be bullish on the $7.89 billion market cap company. The stock increased 0.97% or $2.55 during the last trading session, reaching $264.68. About 258,676 shares traded or 60.82% up from the average. Bio-Rad Laboratories, Inc. (NYSE:BIO) has risen 25.02% since April 18, 2017 and is uptrending. It has outperformed by 13.47% the S&P500.

Since October 31, 2017, it had 1 insider purchase, and 7 selling transactions for $103.28 million activity. WALLMAN RICHARD F had bought 500 shares worth $141,295. Another trade for 1,000 shares valued at $283,450 was made by JOHNSON ROBERT D on Monday, March 12. 74,589 shares valued at $20.66M were sold by JELLISON BRIAN D on Wednesday, January 17. On Tuesday, October 31 KNOWLING ROBERT E JR sold $1.04M worth of Roper Technologies, Inc. (NYSE:ROP) or 4,000 shares.

Analysts await Roper Technologies, Inc. (NYSE:ROP) to report earnings on April, 20 before the open. They expect $2.49 earnings per share, up 18.01% or $0.38 from last year’s $2.11 per share. ROP’s profit will be $256.04M for 27.78 P/E if the $2.49 EPS becomes a reality. After $2.70 actual earnings per share reported by Roper Technologies, Inc. for the previous quarter, Wall Street now forecasts -7.78% negative EPS growth.

Investors sentiment decreased to 0.96 in Q4 2017. Its down 0.32, from 1.28 in 2017Q3. It is negative, as 32 investors sold ROP shares while 212 reduced holdings. 62 funds opened positions while 173 raised stakes. 95.52 million shares or 3.45% less from 98.93 million shares in 2017Q3 were reported. Flossbach Von Storch Ag holds 0.01% or 3,500 shares in its portfolio. Raymond James accumulated 211,278 shares or 0.1% of the stock. Peak6 Lp owns 4,423 shares for 0.01% of their portfolio. Shine Advisory Service Incorporated holds 195 shares. 18,067 were reported by Oppenheimer Asset Mngmt. The Virginia-based Evermay Wealth Mngmt Limited Co has invested 0.08% in Roper Technologies, Inc. (NYSE:ROP). 143,569 were reported by Prudential Financial Incorporated. Mufg Americas invested 0% in Roper Technologies, Inc. (NYSE:ROP). Arrow Corporation accumulated 0.01% or 111 shares. Nippon Life Americas accumulated 0.19% or 9,067 shares. Stifel reported 0.05% stake. Victory holds 0.26% or 472,215 shares in its portfolio. Cibc World Markets Inc has invested 0% in Roper Technologies, Inc. (NYSE:ROP). Gabelli Funds Limited Liability Company accumulated 59,850 shares. Kentucky Retirement Sys Insur Fund owns 2,718 shares or 0.12% of their US portfolio.

Among 13 analysts covering Roper Industries Inc. (NYSE:ROP), 10 have Buy rating, 0 Sell and 3 Hold. Therefore 77% are positive. Roper Industries Inc. had 53 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Buy” rating by Wells Fargo on Thursday, January 18. The firm has “Neutral” rating by JP Morgan given on Friday, March 24. Zacks upgraded the shares of ROP in report on Monday, August 31 to “Sell” rating. The stock of Roper Technologies, Inc. (NYSE:ROP) earned “Buy” rating by Stifel Nicolaus on Thursday, February 15. As per Monday, February 5, the company rating was maintained by Stifel Nicolaus. Robert W. Baird maintained the stock with “Neutral” rating in Tuesday, October 31 report. The stock of Roper Technologies, Inc. (NYSE:ROP) has “Buy” rating given on Monday, July 31 by RBC Capital Markets. The firm has “Hold” rating by Canaccord Genuity given on Sunday, February 4. On Tuesday, October 27 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Buy” rating given on Sunday, June 18 by Oppenheimer.

Investors sentiment increased to 1.13 in Q4 2017. Its up 0.35, from 0.78 in 2017Q3. It improved, as 23 investors sold BIO shares while 89 reduced holdings. 44 funds opened positions while 82 raised stakes. 18.57 million shares or 0.31% more from 18.51 million shares in 2017Q3 were reported. Amer Int Group Inc Inc owns 41,842 shares. Hightower Advisors Lc invested in 0% or 1,597 shares. Texas Permanent School Fund reported 13,664 shares or 0.04% of all its holdings. Pnc Financial Ser Gru Inc reported 0% in Bio-Rad Laboratories, Inc. (NYSE:BIO). Adage Capital Ptnrs Ltd Liability Corporation, Massachusetts-based fund reported 93,500 shares. Canada Pension Plan Board reported 9,400 shares. Millennium Ltd Liability Company owns 180,002 shares. 926 were accumulated by Advisor Prtnrs. Guggenheim Capital Limited invested in 0.02% or 36,979 shares. 10 were accumulated by Oakworth Cap. Westfield Mgmt LP holds 0.27% or 149,043 shares in its portfolio. 4,400 are held by Highland Cap Mgmt Lp. Weaver C Barksdale And Associates Inc invested in 46 shares. Chicago Equity Ptnrs Limited Liability invested in 3,875 shares or 0.03% of the stock. Huntington National Bank & Trust accumulated 65 shares.

Among 5 analysts covering Bio-Rad Laboratories (NYSE:BIO), 3 have Buy rating, 0 Sell and 2 Hold. Therefore 60% are positive. Bio-Rad Laboratories had 20 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) earned “Outperform” rating by Wells Fargo on Wednesday, February 28. The firm earned “Buy” rating on Thursday, October 13 by CL King. On Friday, February 16 the stock rating was downgraded by C.L. King to “Hold”. The firm earned “Buy” rating on Tuesday, March 20 by Wells Fargo. The rating was maintained by Jefferies on Thursday, July 13 with “Buy”. The stock of Bio-Rad Laboratories, Inc. (NYSE:BIO) earned “Buy” rating by Deutsche Bank on Wednesday, June 28. The stock has “Buy” rating by Jefferies on Friday, November 3. The rating was maintained by Jefferies with “Buy” on Friday, October 20. As per Wednesday, September 7, the company rating was maintained by Jefferies. The stock has “Buy” rating by Jefferies on Wednesday, April 12.

Bio-Rad Laboratories, Inc. (NYSE:BIO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: